86 results
DEFC14A
LAB
Standard BioTools Inc.
21 May 24
Proxy in contested solicitation
5:15pm
innovative technologies. Prior to joining the Company, he was chief executive officer of Standard BioTools, LLC from October 2021 until April 2022. Prior
PRER14A
LAB
Standard BioTools Inc.
20 May 24
Preliminary revised proxy
6:03am
in developing and commercializing innovative technologies. Prior to joining the Company, he was chief executive officer of Standard BioTools, LLC from
PREC14A
LAB
Standard BioTools Inc.
10 May 24
Preliminary proxy with contested solicitation
5:16pm
25 years of proven leadership in developing and commercializing innovative technologies. Prior to joining the Company, he was chief executive officer
8-K
EX-99.2
ayfumzbu
5 Jan 24
Standard BioTools Stockholders Approve Merger with SomaLogic
8:53am
425
r00zxg9jm
4 Oct 23
Business combination disclosure
4:30pm
8-K
EX-10.1
ci7rde 327
15 May 23
Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience
5:14pm
8-K
EX-99.1
bq03i4q 54
8 Aug 22
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
4:23pm
8-K
EX-99.1
3bsbyh71fqw 13r
18 Feb 22
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results
12:00am
DEFA14A
sp8p5k95j0yyb
17 Feb 22
Additional proxy soliciting materials
6:35pm
DEFA14A
mtl86ldpshyk9ma78
11 Feb 22
Additional proxy soliciting materials
9:34pm
PRE 14A
dcvzs5xgx0iyiqh
11 Feb 22
Preliminary proxy
9:31pm
8-K
EX-99.1
gy19 3kls71coi
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
DEFA14A
m5sy41oqxj
24 Jan 22
Additional proxy soliciting materials
4:17pm